Portfolio Companies News
February 24, 2017Company’s CEO Acquires Shares in ...
Stockholm, Sweden – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the company’s CEO, Jakob Lindberg acquired 45,000 shares in Oncopeptides for a value of SEK 1.9M in addition to the shares that he subscribed for in the recent share issue in connection with the IPO. For f... read more
February 24, 2017Fusion Pharmaceuticals Launches wit...
HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing led by founding venture investor, Johnson & Johnson I... read more
February 23, 2017Final Results from NICHE Phase III ...
23 February 2017 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today presented the final results of a multi-center Phase III trial in stroke rehabilitation (NICHE trial) assessing the Co... read more
February 23, 2017Wilson Theraputics AB (publ) Year-e...
Feb 23, 2017 Good year-end data gives a promising start to 2017 October 1 – December 31, 2016 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 34.1 M (loss: 21.3) Loss per share, before and after dilution, totaled SEK 1.33 (loss: 16.84) At December 31, cash... read more
February 22, 2017Nordic Nanovector ASA: Invitation t...
Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics for haematological cancers, will announce its fourth quarter and full year 2016 results on Tuesday, 28th of February 2017. A presentation by Nordic N... read more
February 06, 2017Q4 2016 General Market Overview